Chinese Japanese Germany Korea
ChemicalBook >> CAS DataBase List >>1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]-

1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]-

1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]- Structure
1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]- structure
CAS No.
2250024-74-7
Chemical Name:
1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]-
Synonyms
DDO-2093;1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]-
CBNumber:
CB79784685
Molecular Formula:
C29H37ClFN9O3
Molecular Weight:
614.11
MDL Number:
MOL File:
2250024-74-7.mol
MSDS File:
SDS
Last updated:2025-04-18 09:52:46
Request For Quotation

1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]- Properties

Density 1.44±0.1 g/cm3(Predicted)
pka 11.08±0.70(Predicted)
form Solid
color White to off-white

1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]- Chemical Properties, Uses, Production

Uses

DDO-2093 is a potent MLL1-WDR5 protein-protein interaction inhibitor (IC50=8.6 nM; Kd=11.6 nM) with antitumor activity. DDO-2093 selectively inhibits the catalytic activity of MLL complex[1].

in vivo

DDO-2093 (20-80 mg/kg; i.p.; every other day for 21 days) significantly suppresses the tumor size and weight in a dose-dependent manner[1].

Animal Model:Female nude mice (MV4-11 human leukemia cancer xenografts)[1]
Dosage:20 mg/kg, 40 mg/kg and 80 mg/kg
Administration:Intraperitoneal injection; every other day for 21 days
Result:Had the tumor volume growth inhibition (GI) values were calculated to be 13.7%, 37.6% and 63.9% with doses of 20 mg/kg, 40 mg/kg and 80 mg/kg, respectively.

References

[1] Chen W, et al. Discovery of a potent MLL1 and WDR5 protein-protein interaction inhibitor with in vivo antitumor activity [published online ahead of print, 2021 Jun 28]. Eur J Med Chem. 2021;223:113677. DOI:10.1016/j.ejmech.2021.113677

1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]- Preparation Products And Raw materials

Raw materials

Preparation Products

1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]- Suppliers

Global Suppliers ( 2)
Supplier Tel Email Country ProdList Advantage
BOC Sciences 16314854226; +8616314854226 inquiry@bocsci.com United States 19852 58
TargetMol Chemicals Inc. 15002134094 marketing@targetmol.cn China 29874 58
Supplier Advantage
BOC Sciences 58
TargetMol Chemicals Inc. 58

2250024-74-7 (1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]-) Related Search:

EPZ015666 GSK-3326595 UNC-0642 UNC0638 SGC0946
GSK591

1of2

1H-1,2,3-Triazole-4-carboxamide, 1-[3-[(5-amino-2-chloro-4-fluoro-3-methylbenzoyl)amino]-4-(4-methyl-1-piperazinyl)phenyl]-N-[3-(4-morpholinyl)propyl]- DDO-2093 2250024-74-7 C29H37ClFN9O3